My practice is focussed on litigating patents especially patents protecting pharmaceutical products in the UK as well as advising on and co-ordinating European patent litigation strategies more broadly.

I joined the London office of Bird & Bird in 1986 and became a partner in the Intellectual Property Group ten years later in 1996. I offer expertise in UK patent actions and the co-ordination of cross border patent litigation in particular in the area of pharmaceuticals and medical devices. My practice also encompasses regulatory data exclusivity and supplementary protection certificates.

I speak at IP conferences and contribute to leading IP journals on aspects of IP law and litigation. I am also the editor of International Intellectual Property Litigation, published by Butterworths.

  • I have recently run a pharmaceutical (MAb) patent case through to a successful first instance decision and a medical device case through to a successful settlement immediately before trial.
  • All reported (first and/or second instance):
  • Takeda v Roche (MAb)
  • Rhodia v Molycorp (Cerium oxide catalyst)
  • Synthon v Teva (GA process)
  • Novartis v Teva (Rivastigmine)
  • Generics v Teva (GA)
  • Teva v Merck (Timolol/Dorzolamide combination)
  • Actavis v Novartis (Fluvastatin)
  • Actavis v Merck (Finasteride)
  • Abbot v APS (Clarithromycin)
  • Lundbeck v Niche (Citalopram)
  • Teva v Merck (Simvastatin)
  • Teva v Merck (Alendronate)
  • Agilent v Waters (HPLC pump)
  • Hesco v Maccaferri (Gabion)
  • Stephenson v Du Pont (Kevlar composite)
  • UCC v BP (Fluid bed)
  • HCC v BP (Acetyl purification)
  • ICI v Montedison (Polymer composite)
  • PLG v Ardon (Plastic netting)
Education
  • BSc Honours in Chemistry
Admissions
  • Law Society of England & Wales in 1988